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Resident dendritic cells are the predominant
TNF-secreting cell in early renal ischemia–reperfusion
injury
X Dong1,2, S Swaminathan1,2, LA Bachman1, AJ Croatt1, KA Nath1 and MD Griffin1
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Renal ischemia–reperfusion injury (IRI) rapidly induces
production of inflammatory mediators including, and in
particular, tumor necrosis factor (TNF). Possible sources
include resident parenchymal and bone marrow-derived cells
as well as recruited leukocytes. Cell suspensions from kidneys
subjected to IRI were examined by cell separation followed
by in vitro culture and enzyme-linked immunosorbent assay
(ELISA), immunoperoxidase and immunofluorescence
microscopy, and multicolor flow cytometry to determine the
contribution of dendritic cells (DCs) to early production of
TNF and other inflammatory mediators. Secretion of TNF,
interleukin (IL-6), monocyte chemoattractant protein-1
(MCP-1), and regulated on activation normal T cell expressed
and secreted (RANTES) was increased in cell suspensions
from IRI compared with control kidneys and was higher in
DC-enriched preparations. Immunostaining identified
TNFþ ve cells that coexpressed the DC marker CD11c. Flow
cytometry of bone marrow-derived (CD45þ ve) cell
populations at 24 h post-IRI demonstrated that F4/80þ ve/
CD11cþ ve DCs remained proportionately stable and exhibit
higher levels of DC maturation markers, whereas the
proportion of F4/80ve DCs, monocytes, neutrophils, and T
cells increased. Intracellular staining for TNF confirmed that
F4/80þ ve DCs were the predominant TNFþ ve cell and
expressed higher levels than other TNFþ ve cells. In vivo
depletion of DCs from the kidney substantially attenuated
TNF secretion by total and CD45þ ve cells following IRI. The
results uncover a role for resident F4/80þ ve DCs as the
predominant secretors of TNF within 24 h of IRI.
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A critical role for inflammation in the pathophysiology of
acute ischemia–reperfusion injury (IRI) of the kidney is
currently well accepted on the basis of experimental and
clinical studies carried out over the past two decades.1–3 A
number of proinflammatory cytokines and chemokines have
been consistently implicated in the pathophysiology of acute
renal failure among the most prominent of which is tumor
necrosis factor (TNF). Upregulation of mRNA and protein
levels of TNF occurs at a whole-organ level within minutes to
hours of onset of IRI and other forms of acute renal
parenchymal injury.4–7 Less well appreciated at present is the
degree to which individual cell populations contribute to the
early production of TNF and other proinflammatory
cytokines and chemokines within the renal interstitial
compartment.8 Although marginated and infiltrating cell
populations, once recruited, likely secrete such products, the
timing of the initial secretory burst in multiple models, and
the requirement for secreted chemokines to initiate recruit-
ment of these cells indicates a primary role for resident cell
populations. Renal tubular epithelial cells are the predomi-
nant parenchymal cell type in the kidney and clearly can be
induced to synthesize and secrete inflammatory mediators in
vitro or in vivo.9,10 The primary importance of epithelial cell-
derived products, however, has not been established. Other
resident cell types that may participate in the early
inflammatory response to acute renal injury include
endothelial cells, fibroblasts, mesangial cells, tissue macro-
phages, and dendritic cells (DCs).
Although least well studied among these cell types, DCs
may be uniquely involved in the pathogenesis of acute renal
injury for numerous reasons. DCs are known to be
abundantly present throughout the renal interstitial space
and directly interposed between the tubular epithelium and
the peritubular capillaries in the healthy kidney.11–13
Additionally, we and others have demonstrated that renal
DCs (rDCs) undergo dynamic phenotypic alterations in the
context of acute systemic or localized renal parenchymal
injury.14–19 Moreover, in keeping with the well-recognized
role of DCs in initiating cognate immunity, rDC responses to
such insults may include antigen uptake, migration to
draining lymph nodes, and increased capacity for localized
antigen-specific T-cell activation – functional activities which
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occur within 2–7 days of an injurious event.15,17 In this study,
we have examined the contribution of rDCs to the early
release of innate (proinflammatory) immune mediators
within the acutely ischemic kidney in the mouse. Focusing
predominantly on TNF production, the results identify rDCs,
specifically F4/80-expressing rDCs, as potent ‘first respon-
ders’ in the innate response to renal IRI.
RESULTS
CD11cþ ve cells are potent early producers of
proinflammatory mediators in the kidney following IRI
Unilateral renal artery clipping was employed to examine the
contribution of intrarenal DCs to the production of
proinflammatory cytokines and chemokines following IRI.
Cell suspensions of clipped and unclipped kidneys, prepared
24 h after unilateral IRI, were divided into total, CD11c-
enriched, and CD11c-depleted fractions using anti-CD11c
microbeads and magnetic column separation (see Figure 1a)
and were tested in vitro for secretion of TNF, interleukin
(IL-6), monocyte chemoattractant protein-1 (MCP-1), and
regulated on activation normal T cell expressed and secreted
(RANTES) by enzyme-linked immunosorbent assay (ELISA)
of culture supernatants. Secretion of these products by equal
numbers of CD11c-enriched and CD11c-depleted cells was
compared (Figure 1b). As shown, secretion of all four
products was enhanced in culture supernatants from clipped
compared to unclipped kidneys, and was markedly greater in
the CD11c-enriched compared to CD11c-depleted fractions.
The contribution of CD11cþ ve cells to overall secretion of the
same products was examined by comparing concentrations in
culture supernatants from unfractionated cells to those from
equal numbers of CD11c-depleted cells (Figure 1c). For all
products measured, depletion of CD11cþ ve cells from the
ischemic kidney preparations was associated with reduced
concentration. In this, and multiple similar experiments, the
effect of CD11c depletion was most marked for TNF and
RANTES compared with MCP-1 and IL-6. The increased
secretion of proinflammatory products by CD11c-enriched
fractions following IRI was reproduced in two other inbred
mouse strains BALB/C and the lipopolysaccharide (LPS)-
resistant strain C3H/HeJ, data not shown).
To more specifically visualize TNFþ ve cells within kidney
cell suspensions, and to colocalize TNF and CD11c expres-
sion, cell preparations from clipped and control kidneys were
examined by immunoperoxidase staining with anti-TNF and
by three-color immunofluorescent staining with anti-TNF,
anti-CD11c, and 40,6-diamidino-2-phenylindole (DAPI)
(Figure 2). Compared to control kidneys, cell preparations
from IRI kidneys contained numerically greater numbers of
TNFþ ve cells that were predominantly small and rounded
(Figure 2a and b). Immunofluorescence microscopy con-
firmed the presence of TNF and CD11c double-positive cells
within cell preparations from IRI kidneys (Figure 2c). This
series of experiments was interpreted, as indicating that
CD11cþ ve cells, presumably DCs, constitute potent inducible
secretors of TNF and other proinflammatory mediators
within 24 h of IRI.
CD11c+ve DCs are resident intrarenal cells that are distinct
from infiltrating monocytes, neutrophils, and T cells and
undergo maturation in situ following IRI
To more definitively distinguish rDCs from other intrarenal
cell populations and to further characterize TNFþ ve DCs
during IRI, flow cytometric analysis was undertaken.
Characterization of CD45þ ve/CD11cþ ve cells from healthy
mouse kidneys revealed that, consistent with DCs, they were
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Figure 1 | CD11cþ ve cells are a potent source of TNF, IL-6, MCP-1,
and RANTES in kidney cell suspensions following IRI. (a) Examples
of flow cytometric analysis of total kidney cell suspensions and of
CD11c-enriched and CD11c-depleted fractions prepared by
anti-CD11c magnetic column separation. Proportions of each cell
population stained positively for CD45 and CD11c are indicated.
(b) Cell suspensions from clipped (IRI) kidneys and unclipped (Ctrl.)
kidneys of a group of four mice were prepared 24 h after being
subjected to 30 min of unilateral renal artery clipping. The cells were
separated into CD11c-enriched and CD11c-depleted fractions, and
were cultured overnight in equal numbers. Results are shown for
ELISAs of culture supernatants from the cell fractions expressed as
mean7s.d. concentration in ng/ml. Concentrations of all four
products were higher in supernatants from CD11c-enriched fractions,
and were increased in CD11c-enriched cells from IRI compared to Ctrl
kidneys. (c) Unsorted and CD11c-depleted cell fractions from the
same organs were cultured overnight in equal numbers. Results are
shown for ELISAs of culture supernatants from the cell fractions
expressed as mean7s.d. concentration in ng/ml. For IRI kidneys,
concentrations of all four products were higher in supernatants from
unsorted compared with CD11c-depleted fractions. For control
kidneys, only TNF and RANTES were higher in unsorted fractions.
Levels of all products were higher in all fractions from IRI compared
with the equivalent fraction of Ctrl kidneys. w¼ Po0.05 for
CD11c-enriched vs CD11c-depleted (b) or total cells vs CD11c-
depleted (c). z¼ Po0.05 for IRI vs Ctrl kidneys.
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positive for markers of professional antigen-presenting cells
(MHC II, CD80, CD86, CD54 (ICAM-1), CD1d) but
negative for subset markers of lymphoid organ DCs (CD8a,
CD4, CD205 (DEC205), 33D1). They were also positive for
CD11b and CD16/CD32 (FcRg II/III) but negative for the
tissue macrophage markers CD169 (sialoadhesin) and CD204
(scavenger receptor type A). A subset of the renal CD45þ ve/
CD11cþ ve cells, however, also expressed surface F4/80 and
intracellular CD68 suggesting a phenotypic overlap with
macrophages (Figure S9). Cell suspensions, prepared 24 h
after unilateral IRI from clipped and control kidneys, were
stained for the pan-leukocyte marker CD45 in combination
with CD11c, F4/80, and either Ly6C, Ly6G, or CD3e (to
distinguish monocytes, neutrophils, and T cells, respectively).
T cells were further stained for CD4 and CD8. Examples of
staining for CD45, CD11c, Ly6C, and F4/80 and of the
relative quantification of positively stained subsets are shown
in Figure 3a. Results of the overall analysis of CD45þ ve cell
subsets in clipped and control kidneys from a representative
experiment, expressed as percent of the total cell suspensions
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Figure 2 | Direct identification of CD11cþ ve, TNF-expressing cells
in immunostained cell preparations from ischemic kidneys.
(a) Cell suspensions of ischemic and control kidneys from three adult
mice were prepared 24 h following a 30 min unilateral renal artery
clipping, were cultured on coverslips in the presence of a
Golgi-export inhibitor, then fixed and stained by immunoperoxidase
method with anti-TNF or isotype control antibody, and examined by
light microscopy for positively stained cells. Isotype control staining
yielded no positive staining. Small, rounded, positively stained cells
were readily detected among anti-TNF stained cells of ischemic
kidneys. Similar positively stained cells were detected rarely among
anti-TNF stained cells of control kidneys. (b) Graphical representation
of cell counts per high-power field are expressed for each pair of
ischemic and control kidneys as mean7s.d. for cell counts from 10
individual fields for each organ. w¼ Po0.05 for ischemic vs control
kidney. (c) Representative example of immunofluorescence
microscopy of cell preparation from an ischemic kidney following
culture in the presence of a Golgi-export inhibitor and staining with
anti-CD11c-PE, anti-TNF-AF488, and DAPI. Overlaid images
demonstrate multiple cells staining for both CD11c and TNF.
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Figure 3 | Elucidation and enumeration of CD45þ ve cell
populations in ischemic and control kidneys. Cell suspensions
from kidneys of adult mice 24 h following a 30 min unilateral renal
artery clipping were stained for CD45 in combination with antibodies
against CD11c (DC marker), Ly6C (monocyte marker), Ly6G
(neutrophil marker), and CD3e (T-cell marker). DCs were additionally
stained for F4/80. T cells were additionally stained for CD4 and CD8.
(a) Examples of multicolor flow cytometric analyses to distinguish
DCs from monocytes in cell suspensions from unclipped (Ctrl) and
clipped (IRI) kidneys and to quantify total CD45þ ve cells (left dot
plots), CD45þ ve/CD11cþ ve/Ly6Cve and CD45þ ve/CD11cve/
Ly6Cþ ve cells (middle dot plots) and CD45þ ve/CD11cþ ve/F4/80þ ve
and CD45þ ve/CD11cþ ve/F4/80ve cells (right dot plots). For cell
populations of interest (boxed regions), the quantification is
expressed as percentage of the total viable cells. (b) Results of a
complete analysis of CD45þ ve cell populations from Ctrl and IRI
kidneys of a group of four mice subjected to unilateral renal artery
clipping are shown graphically and expressed as mean7s.d. percent
of the total population of kidney cells analyzed. Staining definitions
for each cell populations were as follows CD4-pos T cells: CD45þ ve/
CD11cve/CD3eþ ve/CD4þ ve; CD8-pos T cells: CD45þ ve/CD11cve/
CD3eþ ve/CD8þ ve; neutrophils: CD45þ ve/CD11cve/Ly6Gþ ve;
monocytes: CD45þ ve/CD11cve/Ly6Cþ ve; F4/80-neg DCs: CD45þ ve/
CD11cþ ve/Ly6Cve/F4/80ve; and F4/80-pos DCs: CD45þ ve/
CD11cþ ve/Ly6Cve/F4/80þ ve. All CD45þ ve cell populations were
proportionately increased in IRI kidneys with the exception of
F4/80-pos DCs, which were unchanged. w¼ Po0.05 for IRI compared
with Ctrl kidneys.
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at 24 h postclipping, are presented in Figure 3b. Compared
to contralateral, nonischemic kidneys, IRI resulted in an
increased proportion of total CD45þ ve cells and of mono-
cytes (CD45þ ve/CD11cve/Ly6Cþ ve), neutrophils (CD45þ ve/
CD11cve/Ly6Gþ ve), CD8 T cells (CD45þ ve/CD11cve/
CD3eþ ve/CD8þ ve), CD4 T cells (CD45þ ve/CD11cve/
CD3eþ ve/CD8þ ve), and F4/80ve DCs (CD45þ ve/CD11cþ ve//
Ly6Cve/F4/80ve). In contrast, the proportion of F4/80þ ve DCs
(CD45þ ve/CD11cþ ve/Ly6Cve/F4/80þ ve) remained unchanged.
In separate experiments, higher expression levels of DC
maturation markers were demonstrated for CD45þ ve/
CD11cþ ve/F4/80þ ve cells from ischemic kidneys 24 h after renal
artery clipping. As shown in Figure 4a and b, IRI was associated
with relatively larger cell size (as reflected by forward scatter) and
higher surface levels of MHC II, CD80, CD86, CD40, and CD54
(ICAM-1) on these cells. These data demonstrate that (a) F4/
80þ ve DCs constitute a major proportion of the resident bone
marrow-derived cells within the healthy kidney. (b) During the
first 24 h following IRI, intrarenal F4/80þ ve DCs remain
proportionately stable, whereas other leukocyte populations are
proportionately increased. (c) The F4/80þ ve DCs within ischemic
kidneys exhibit a more mature phenotype than those of
nonischemic kidneys.
Resident F4/80þ ve DCs are the most significant cell
population expressing high TNF levels following IRI
The involvement of bone marrow-derived (CD45þ ve)
cells and the relative contributions of different CD45þ ve
lineages in TNF production following IRI was further
evaluated by surface and intracellular staining with flow
cytometric analysis. As shown in Figure 5a and b, IRI resulted
in a proportionate increase in TNFþ ve cells within total
kidney cell suspensions. The large majority of the TNFþ ve
cells from ischemic kidneys were CD45þ ve (Figure 5c).
Additional surface staining for DCs (CD11c), monocytes
(Ly6C), neutrophils (Ly6G), and T cells (CD3e) indicated
that, while DCs constituted 20–25% of all CD45þ ve cells
from ischemic kidneys, they represented 55–60% of the
CD45þ ve/TNFþ ve cells at this time point (Figure 6a). The
second most numerous CD45þ ve/TNFþ ve cells were
Ly6Cþ ve monocytes representing 18–22% of the total.
Neutrophils and T cells were rare among TNFþ ve cells.
Importantly, when mean fluorescence intensity for anti-TNF
staining was compared between DCs and monocytes from
ischemic kidneys, the result indicated significantly higher
TNF expression in DCs (Figure 6b). The specific predomi-
nance of F4/80-expressing DCs among TNFþ ve cells of
ischemic kidneys was confirmed by CD45 enrichment of
kidney cell suspensions 24 h after renal artery clipping
followed by surface staining for CD11b, CD11c, and F4/80,
and intracellular staining for TNF. As illustrated in Figure 7,
the large majority of TNFþ ve cells in this cell preparation
were located within a dense cluster of CD11cþ ve/CD11bþ ve/
F4/80þ ve cells.
In a final experimental strategy, depletion of intrarenal
DCs was carried out by intravenous injection of clodronate-
containing liposomes before unilateral renal artery clipping.
As illustrated in Figure 8a, clondronate (but not inert
(phosphate-buffered saline (PBS)) liposomes resulted in
discrete depletion of CD45þ ve/CD11cþ ve cells from the
kidney without depletion of other CD45þ ve cells (including
CD45þ ve/Ly6Cþ ve monocytes, Figure S10). Twenty-four
hours after unilateral clipping, total, CD45-enriched, and
CD45-depleted cell fractions were prepared from clipped and
unclipped kidneys of mice that were pretreated with
clodronate-containing liposomes or PBS liposomes. Flow
cytometric analysis of the cell preparations confirmed that
CD45þ ve cells from ischemic and nonischemic kidneys of
clodronate-treated animals were devoid of CD11cþ ve DCs
but were otherwise similar in composition to those from
animals treated with inert liposomes (data not shown).
Secretion of TNF was compared for equal numbers of CD45-
enriched and CD45-depleted cells, and for equal numbers of
unfractionated and CD45-depleted cells (Figure 8b). In
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Figure 4 | Upregulation of DC maturation markers on F4/80þ ve
DCs in kidneys following IRI. Cell suspensions from kidneys of adult
mice (n¼ 4) 24 h following a 30 min unilateral renal artery clipping
were stained for CD45, CD11c, and F4/80 in combination with a panel
of antibodies against DC maturation markers (MHC II (I-Ab), CD80,
CD86, CD54, and CD40). (a) Representative dot plots are shown for
unclipped (Ctrl) and clipped (IRI) kidney preparations gated on
CD45þ ve/CD11cþ ve cells (total DCs) and analyzed for forward scatter
and anti-F4/80 staining. Gating of F4/80þ ve DCs and F4/80ve DCs is
indicated (boxes). Graphical representation of the results for a group
of four mice is shown and indicates increased forward scatter of
F4/80þ ve (but not F4/80ve) DCs in IRI compared with Ctrl kidneys.
Results are expressed as mean7s.d. of the median fluorescence
intensities. (b) Graphical representation of surface staining levels
(mean7s.d. of mean fluorescence intensity) for MHC II, CD80, CD86,
CD54, CD40 on F4/80þ ve/CD11cþ ve DCs from the same pairs of IRI
and Ctrl kidneys. w¼ Po0.05 for IRI kidney vs Ctrl kidney.
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agreement with previous experiments, IRI was associated
with increased TNF secretion by kidney-derived cell suspen-
sions. Virtually all the TNF secreted was derived from
CD45þ ve cells. In addition, however, depletion of intrarenal
DCs before onset of IRI resulted in substantial reduction
in the amount of TNF secreted by total kidney cells as well as
by CD45þ ve cells on a cell-for-cell basis. This result
provided confirmation that maximal intrarenal TNF produc-
tion following IRI is dependent on the presence of resident
DCs.
DISCUSSION
The kidney is susceptible to functional decline following
systemic events such as hypotension, septicemia, or drug/
toxin exposure, and following localized perturbations
including those that interrupt organ blood flow or urinary
outflow. The renal dysfunction associated with these diverse
causes of acute renal parenchymal injury results, at least in
part, from the generation and secretion of innate immune
mediators as well as the coordinated recruitment and
functional activation of immune cell populations from the
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Figure 5 | TNF-expressing cells are increased in kidneys following IRI and are predominantly bone marrow derived (CD45þ ve). Cell
suspensions were prepared from unclipped (Ctrl) and clipped (IRI) kidneys of adult mice (n¼ 3) 24 h following a 30 min unilateral renal artery
clipping. The cells were surface stained for CD45 and intracellularly stained with Rat IgG1-APC or anti-TNF-APC. (a) Representative dot plots
of forward scatter vs rat IgG-APC or anti-TNF-APC fluorescence are shown for total analyzed cells from Ctrl and IRI kidney. TNFþ ve cells (lower
dot plots) are readily distinguished and gated for further analysis. Quantification is indicated as percent of the total cells analyzed for each
dot plot. (b) Graphical presentation of the mean7s.d. percent of total cells stained with anti-TNF compared with rat IgG1 in Ctrl and IRI kidneys.
w¼ Po0.05 for anti-TNF vs rat IgG1, z¼ Po0.05 for IRI vs Ctrl. (c) Representative dot plots for side scatter vs anti-CD45 fluorescence are shown
for total cells and for TNFþ ve cells from one of the four IRI kidneys from the same experiment (left panel). CD45þ ve cells are readily
distinguished (boxes) representing 8.5% of the total cells and 90% of the TNFþ ve cells. Results for all four IRI kidneys are shown graphically
(right panel) as mean7s.d. of %CD45þ ve among total cells and TNFþ ve cells.
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circulation.1–3,20 Cellular sources of the proinflammatory
mediators of acute renal injury are multiple and likely vary
during the time course of postinjury organ dysfunction. The
results of this study indicate that resident DCs are a major
secretor of TNF and other proinflammatory mediators
during the first 24 h following interruption of renal blood
flow in this model of IRI.
Initial experiments indicated that CD11c-enriched pre-
parations from kidney cell suspensions secreted substantially
greater amounts of the cytokines TNF and IL-6, and the
chemokines MCP-1 and RANTES compared with an
admixture of renal cells depleted of CD11c-expressing
constituents. The proportionate contribution of CD11cþ ve
cells to overall production of these mediators (determined by
comparing secretion by the total cell suspension with equal
numbers of CD11c-depleted cells) was variable. In repeated
experiments carried out at 24 h post-IRI, we found that
CD11c-depletion was associated with 475% reduction of
TNF and RANTES, 40–60% reduction in IL-6 and 20–30%
reduction of MCP-1. It should be noted that these
experiments alone do not formally rule out the presence of
additional rare cell types capable of producing high levels of
one of more of these soluble products within the CD11c-
depleted fractions.
Each of the proinflammatory mediators measured has
been linked experimentally with the severity of renal
structural and functional disturbance following IRI and
other forms of acute injury.21–25 Furthermore, a broad range
of cytokines and chemokines are elucidated within the
injured kidney of which those assayed in this study represent
a relatively restricted sample. Nonetheless, we chose to focus
subsequent experiments more precisely on defining the
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Figure 6 | DCs are the predominant high-level TNF-producer among CD45þ ve cell subsets in kidneys following IRI. Cell suspensions from
kidneys of adult mice 24 h following a 30 min renal artery clipping were stained for CD45, CD11c, and intracellular TNF in combination with
antibodies against Ly6C (monocyte marker), Ly6G (neutrophil marker), or CD3e (T-cell marker). (a) Left panel: representative dot plots used
to distinguish DCs from monocytes among total CD45þ ve cells and CD45þ ve/TNFþ ve are shown for one of the four IRI kidneys. The percentage
of the gated cells that are CD11cþ ve/Ly6Cve (DCs) and CD11cve/Ly6Cþ ve (monocytes) are indicated. Right panel: Results of a complete
analysis of the proportions of DCs, monocytes, neutrophils, and T cells among total CD45þ ve cells and CD45þ ve/TNFþ ve cells are shown
graphically for IRI kidneys expressed as mean7s.d. percent of the gated cells. Staining definitions for each cell populations were as follows:
DCs: CD45þ ve/CD11cþ ve/Ly6Cve; monocytes: CD45þ ve/CD11cve/Ly6Cþ ve; neutrophils: CD45þ ve/CD11cve/Ly6Gþ ve; and T cells: CD45þ ve/
CD11cve/CD3eþ ve. w¼ Po0.05 for total CD45þ ve vs CD45þ ve/TNFþ ve. (b) Left panel: representative histograms are shown for fluorescence
level of TNFþ ve DCs (CD45þ ve/CD11cþ ve/Ly6Cve/TNFþ ve) and monocytes (CD45þ ve/CD11cþ ve/Ly6Cve/TNFþ ve) from one of the four IRI
kidneys. Right panel: graphical presentation of TNF expression level (mean7s.d. of the mean fluorescence intensities) of TNFþ ve DCs and
monocytes from four IRI kidneys. z¼ Po0.05 for TNFþ ve DCs vs TNFþ ve monocytes.
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contribution of intrarenal DCs and other cell populations to
TNF production. This focus stemmed, primarily, from the
well-established nonredundant role for TNF in determining
the severity of acute renal dysfunction following sepsis, IRI,
and other forms of kidney injury.20,26–28 In animal models of
IRI, increased whole-kidney TNF content has been repeatedly
demonstrated within 1–4 h of reperfusion and blockade or
genetic absence of TNF effector function attenuates subse-
quent cellular infiltration, epithelial damage, and renal
functional impairment.4,26,28 Intracellular signaling through
TNF receptors is associated with upregulation of adhesion
molecules and additional proinflammatory mediators as well
as with the triggering of apoptosis in renal tubular epithelial
cells.28
A substantial number of studies have demonstrated the
capacity for bone marrow- and monocyte-derived DCs as
well as DCs from lymphoid tissues to secrete high levels of
TNF and other innate immune mediators following the
application of maturation stimuli.29–31 Despite this, the in
situ identification of organ-specific DCs as predominant
sources of TNF in the early course of tissue injury and
immune-mediated diseases has been reported only infre-
quently.32 In the case of acute renal IRI, secretion of TNF is
conventionally ascribed to infiltrating monocytes, resident or
infiltrating macrophages, and tubular epithelial cells.3,10,33,34
Although there is cumulative evidence that these cell
populations represent potential sources of inducible TNF
production in the post-IRI kidney, our results in the
currently employed unilateral renal artery clip model indicate
that the largest population of cells highly positive for
intracellular TNF staining at 24 h expressed DC surface
markers and exhibited characteristic features of DC matura-
tion including upregulation of MHC II and multiple
costimulatory ligands. Although infiltration of the postis-
chemic kidney by monocytes, neutrophils, helper, and
cytotoxic T cells and, to a lesser extent, F4/80ve DCs was
well demonstrated during these experiments, only monocytes
were also observed to comprise a notable proportion
(approximately 20%) of the TNFþ ve cells. Comparison of
TNFþ ve monocytes and DCs indicated that the latter were
more numerous and expressed higher levels of TNF.
Furthermore, predepletion of DCs from the kidney was
associated with marked reduction in TNF secretion by
CD45þ ve kidney cells following IRI. Importantly and in
keeping with reported effects of clodronate-containing
liposomes on splenic DC populations,35 this intervention
was associated primarily with depletion of resident interstitial
DCs from the kidney and did not, in these experiments,
result in absence or marked reduction of monocytes (Figure
S10), neutrophils, or T cells among the CD45þ ve fractions of
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Figure 8 | Depletion of intrarenal DCs before onset of IRI results
in reduced secretion of TNF by total and CD45þ ve kidney cells.
(a) Dot plots showing examples of kidney cell suspensions from
mice treated 48 h previously with inert (PBS) liposomes or with
clodronate-containing liposomes (clodronate) and surface stained for
CD45 and CD11c. The percent of total cell suspensions that were
CD45þ ve/CD11cve and CD45þ ve/CD11cþ ve are indicated for the
two samples. (b) Results are shown of ELISA for TNF carried out on
culture supernatants from kidney cell fractions of mice pretreated
with inert (PBS) liposomes or with clodronate-containing (clodronate)
liposomes (n¼ 4 each) then subjected to 30 min of left renal
artery clipping. Cells fractions were prepared 24 h following IRI. Left
graph: results are shown for equal numbers (105 cells/well) of
CD45-enriched and CD45-depleted cells from clipped (IRI) and
unclipped (Ctrl) kidneys from the two groups. Right graph: results
are shown for equal numbers (5 105 cells/well) of unfractionated
(total) cells and CD45-depleted cells from clipped (IRI) and unclipped
(Ctrl) kidneys of the two groups. w¼ Po0.05 for CD45-enriched vs
CD45-depleted (left graph) or total cells vs CD45-depleted (right
graph). z¼ Po0.05 for IRI vs Ctrl kidney for each group. z¼ Po0.05
for PBS vs equivalent clodronate sample.
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ischemic kidneys. It should be noted that Day et al.34 and Jo
et al.36 have recently reported that clodronate administration
results in amelioration of acute renal injury following renal
artery clipping in rodent models. In these studies, however,
clodronate therapy was clearly also associated with systemic
depletion of macrophages and circulating monocytes. Thus,
although our results with clodronate-mediated depletion
serve as further confirmation that DCs are the predominant
local source of TNF following IRI, they cannot be interpreted
as indicating that depletion of DCs alone is sufficient to
reduce the severity of renal functional impairment. TNF
production by CD45 cell populations (which presumably
includes tubular epithelial cells, fibroblasts, endothelial cells,
and mesangial cells) was consistently minimal by flow
cytometry as well as by magnetic column separation with
anti-CD45 microbeads.
Our results highlight an existing ambiguity in the
distinction between resident macrophages and DCs in
the healthy and injured kidney. Ultrastructural analyses of
the renal interstitium indicate that DCs are abundant in the
peritubular interstitial space, are morphologically distinct
from macrophages, and express high surface levels of MHC II
in the resting state.11–13 In contrast, cells with morphological
characteristics of macrophages are sparse and confined,
during health, to the periarterial connective tissue, capsule,
and pelvic wall.11,12 Recently, Soos et al.19 have unequivocally
confirmed the extent of the DC network within the renal
interstitium of the healthy kidney and have demonstrated the
degree to which these cells probe the interstitial microenvir-
onment. This and other studies focused on phenotypic and
functional properties of rDCs have confirmed additional
expected characteristics including expression of CD11c (a
DC-specific marker in the mouse); regulated expression of
costimulatory ligands; antigen-uptake and presentation
capacity; and migration to T-cell zones of draining lymph
nodes following maturational stimuli.14,15,17,18,37 In keeping
with Soos et al. 19 and Kruger et al.,18 we observe here that a
proportion of rDCs express surface or intracellular proteins
often considered to represent macrophage markers – F4/80,
CD68, and FcRgII/III. Despite this apparent phenotypic
overlap with resident macrophages, we have shown that these
cells migrate out of the injured kidney to draining lymph
nodes between 24 and 48 h following an acute injury – a
classic DC functional characteristic.15 The current results also
indicate that CD11cþ ve/F4/80þ ve cells in 24 h ischemic
kidneys have higher surface levels of DC maturation markers
such as MHC II and costimulatory ligands than those of
control kidneys. Although possible explanations for the
increased maturation marker levels on intrarenal DCs after
IRI include replacement of the original DCs with new, more
mature DCs, this is less likely given the fact that this
population did not change proportionately within the
kidney. Furthermore, we have observed increased surface
maturation markers and TNF production by intrarenal DCs
as little as 4 h following IRI (X Dong and M Griffin,
unpublished observation). Thus, we favor the conclusions
that, in the mouse at least, F4/80þ ve or CD68þ ve cells in the
renal interstitium during health are more likely to represent
DCs than macrophages18,34,38–40 and that these resident
intrarenal DCs undergo maturation in situ in the early
postischemic time period. Although not within the scope of
the current study, it is likely that, at later time points
following acute injury, the interstitial space contains a
dynamic mixture of persistent resident DCs as well as new
populations of DCs and macrophages differentiated from
influxing monocytes. Our results do not, therefore, preclude
critical roles for infiltrating activated macrophages in the
progression of intrarenal inflammation following acute injury
and in modulating the extent of eventual tissue repair.33
Given the divergent immunological roles for DCs and
macrophages as well as the potential to individually target
them for therapeutic purposes,33,41 continued efforts at
phenotypic and functional distinction between DCs and
macrophages in the context of kidney disease models is
merited.
The presence of F4/80þ ve DCs in the renal interstitium
has also been demonstrated by immunostaining of renal
tissue sections18,19,40 and it is interesting to note that, in some
studies, this population was most clearly localized to the
medulla and juxtamedullary cortex – a region that is more
susceptible to severe cellular injury following IRI.19,40 It is
possible, therefore, that exposure of the F4/80þ ve DCs to
endogenous-activating factors in this region of high cellular
injury results in their preferential upregulation of maturation
markers and production of TNF. Alternatively, an element of
the vulnerability of this region to cellular injury following IRI
could be the presence of high levels of DC-produced TNF
and other factors. Although it is beyond the scope of this
study to determine whether either or both of these relation-
ships exist, additional investigation may clarify the signifi-
cance of the localization of F4/80þ ve DCs within the kidney.
It is also of interest to consider which endogenous-activating
factors may be directly responsible for stimulating TNF
secretion and other IRI-related responses of renal F4/80þ ve
DCs. Recent progress in understanding innate immune
responses to infectious and noninfectious forms of tissue
injury have identified a broad range of candidate DC-
activating factors released by parenchymal cells exposed to
acutely stressful conditions including reactive oxygen species,
heat-shock proteins, extracellular matrix components, poly-
nucleotides, and other diverse ‘danger signals’ or ‘alar-
mins.’41–45 As tissue-resident DCs express multiple pattern
recognition receptors, we would speculate that an array of
such endogenous ligands contribute to the DC responses we
have observed in the current model. Nonetheless, the role of
individual candidate activators and receptors (e.g., toll-like
receptors) will be testable in the context of existing mouse
strains and reagents.41,45
In conclusion, this study provides novel evidence that
resident DCs constitute the predominant ‘first responders’ in
the secretion of TNF and other inflammatory mediators that
participate in the early pathophysiological events leading to
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functional impairment in the acutely injured kidney. Being
localized to the peritubular epithelial space and, as we show
here, capable of rapid, high-level production of key cytokines
and chemokines, rDCs are uniquely positioned to respond to
endogenous activators of innate immunity, to instigate
secondary responses in renal epithelial and endothelial cells,
and to participate in the recruitment of additional circulating
cells to the kidney. We propose that further characterization
of this cell population in the injured kidney will identify
opportunities for manipulating the contributions of innate as
well as cognate immunity to acute kidney failure.
MATERIALS AND METHODS
Animals and reagents
Adult C57BL/6 (B6) mice were purchased from The Jackson
Laboratory, Bar Harbor, Maine and housed in a specific pathogen-
free facility. Tissue culture was carried out in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal calf serum
fetal calf serum (FCS). Detection agents (clone numbers) used in
various experiments were anti-CD11c-PE and -biotin (HL3), anti-
CD45-biotin (104), anti-Ly6C-FITC (AL-21), anti-Ly6G-FITC
(1A8), anti-CD3e-FITC (2C11), anti-CD80-PE (16-10A1), anti-
CD86-PE (GL1), anti-CD54-PE (3E2), anti-CD40-PE (3/23), anti-I-
Ab-PE (AF6-120.1), anti-CD8a-PE (53-6.7), anti-CD4-PE (L3T4),
anti-CD1d-FITC (1B1), anti-CD11b-PE (M1/70), anti-TNF-APC, -
AF488 and purified (MP6-XT22), rat IgG1-APC and -AF488 (R3-
34), rat IgG2b-PE and -FITC (a95-1), hamster IgG1-PE (anti-TNP),
anti-rat Ig-biotin, streptavidin–cyChrome and -HRP (all from BD
Pharmingen, San Jose, CA, USA); anti-F4/80-APC (A3-1), an-
tiCD169-FITC (3d6.112), anti-CD16/CD32-AF647 (FCR4G8), anti-
CD68-AF647 (FA-11), anti-CD204-AF647 (2F8), anti-CD205-
AF647 (NLDC-145), rat IgG2a-PE, -FITC and -AF647 (YTH71.3)
(all from Serotec Inc., Raleigh, NC, USA); 33D1-PE (from
eBioscience, San Diego, CA, USA).
Mouse model of IRI and preparation of kidney cell
suspension
Unilateral renal artery clipping was carried out for 30 min in adult
mice by pentobarbitol anesthesia as described previously.15 Kidneys
were dissected, cut into 1–2 mm3 pieces, placed in DMEM contain-
ing 1.6 mg/ml collagenase I (Sigma Aldrich, St Louis, MO, USA),
and 200mg/ml DNase I (Roche Applied Science, Indianapolis, IN,
USA) for 40 min at 371C with intermittent agitation, washed,
resuspended in DMEM/200mg/ml DNase I at room temperature for
15 min, and washed twice in DMEM. Following erythrocyte lysis,
cells were resuspended in DMEM/10% FCS or FACs buffer (PBS/
0.2% bovine serum albumin (BSA)/0.02%NaN2). To ensure that
large cellular clumps and noncellular material were not included,
kidney cell suspensions to be used for flow cytometry were allowed
to settle for 20 min following which the upper two-thirds were
removed for use in these assays.
Magnetic column enrichment of CD11cþ ve cells, cell culture,
and ELISA of culture supernatants
Magnetic bead enrichment and depletion of DCs from kidney cell
suspensions were carried out using anti-CD11c-coated microbeads
and the miniMACSTM separation system (Miltenyi Biotech Inc.,
Auburn, CA, USA) according to the manufacturer’s instructions.
Experiments involving culture of total cells and magnetic column
cell fractions were carried out overnight in 96-well round bottom
plates following which supernatants were removed and subjected to
ELISA for TNF, IL-6, (BD Pharmingen), MCP-1 and RANTES
(R&D Systems, Minneapolis, MN, USA). For experiments compar-
ing CD11c-enriched and CD11c-depleted fractions, cells were plated
at 105 per well with 3–6 wells for each condition. For experiments
comparing unsorted and CD11c-depleted fractions, cells were plated
at 5 105 per well with 3–6 wells for each condition.
Immunohistochemistry and immunofluorescence microscopy
Cell suspensions from ischemic and control kidneys were cultured in
DMEM/10% FCS containing 1 mg/ml GolgiPlugTM (BD Pharmingen)
for 4 h at 371C then lifted and added to wells of adhesion slides (Erie
Scientific, Portsmouth, NH, USA). Immunoperoxidase staining was
carried out as described previously15 using rat anti-TNF or isotype
control followed by biotinylated anti-rat antibody, then developed
using Vectorstains Elite ABC solution (Vector Laboratories Inc.,
Burlingame, CA, USA) followed by diaminobenzidine (DAB)
substrate solution. Slides were examined by light microscopy and
positively stained cells were enumerated in 10 high-power fields per
slide. Immunofluorescence staining was carried out as described
previously15 using rat anti-TNF and hamster anti-CD11c antibodies
or isotype controls followed by Alexa Fluors 488-conjugated anti-
rat IgG and Alexa Fluors 594-conjugated goat-anti hamster IgG.
The slides were mounted using VECTASHIELDs mounting
medium with 40,6-diamidino-2-phenylindole (Vector Laboratories)
and examined under confocal laser-scanning microscopy (LSM510,
Carl Zeiss, Goettingen, Germany).
Flow cytometric analysis
Aliquots of cells were incubated in FACs buffer (PBS/0.2%BSA/0.
02%NaN2) at 41C with combinations of fluorochrome-labeled and/
or biotinylated antibodies followed by fluorochrome-labeled strep-
tavidin. Intracellular staining of kidney cells was carried out using
the Cytofix/CytopermTM kit (BD Pharmingen). For experiments
involving intracellular staining of TNF, suspensions were cultured
for 8 h in DMEM/10% FCS containing 1 ml/ml of GolgiPlugTM
reagent (BD Pharmingen) before staining. Samples were analyzed
using a fluorescence-activated cell sorter (FACS) CaliburTM flow
cytometer and CellquestTM software (BD Pharmingen).
Clordonate liposome-mediated depletion of intrarenal DCs
Clodronate (dichloromethylene bisphosphonate, Sigma Aldrich)
liposomes were prepared by the method of Van Rooijen et al.46
Briefly, phosphatidylcholine (86 mg of egg lecithin in 4.3 ml
chloroform) and cholesterol (8 mg in 10 ml chloroform) were
evaporated by rotation under reduced pressure. Clodronate (2.5 g in
10 ml of H2O) was added to disperse the lipid gently. The lipid
suspension was placed under N2 for 2 hours, sonicated, washed, and
resuspended in 4 ml of sterile PBS. Inert liposomes were prepared by
the same protocol with PBS alone. Adult mice were injected
intravenously with 200 ml of clodronate- or PBS-liposomes on 2
consecutive days. Mice were subjected to unilateral renal artery
clipping 48 h after the second injection.
Statistical analysis
Numerical results for individual experimental groups were expressed
as mean7s.d. and were compared using paired (for left vs right
kidney experiments) or unpaired (for all other comparisons) two-
sided Student’s t-test with significance assigned to Po0.05.
Experiments were carried out between three and six times to ensure
reproducibility.
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SUPPLEMENTARY MATERIAL
Figure S9. Flow cytometric histograms are shown for staining of
CD45þ ve/CD11cþ ve cells from suspensions of healthy adult mouse
kidneys.
Figure S10. Results of staining and quantification of DCs and
monocytes are shown for ischemic and control kidneys of mice pre-
treated with inert (PBS) liposomes or clodronate-containing lipo-
somes.
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